ArticleMolecular medicine reports2026
[Expression of Concern]
Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- ExpressionOfConcernFor
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, regarding the histological images shown in Fig. 1B on p. 149, the "Ctrl" and "GLPs 5μg/ml" data panels contained an overlapping section of data, suggesting that these data panels were derived from the same original source where different experimental conditions were reported. In addition, a concern was raised regarding the antibody that had been used to probe for p21 in the western blot experiments in Fig. 5 (cat. no. sc‑136020, purchased from Santa Cruz Biotechnology, Inc.), since apparently this antibody is specific for a different protein, sometimes referred to as p21‑ARC, which is related to the actin cytoskeleton. The authors have been contacted by the Editorial Office to offer an explanation for these apparent anomalies in the presentation of the data in their paper, and we are awaiting their response. Due to the fact that we have been made aware of potential issues surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office continues to investigate this matter further. [Molecular Medicine Reports 17: 147‑157, 2018; DOI: 10.3892/mmr.2017.7904].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.